Are 'platform plays' here to stay?; The Aduhelm saga continues to unfold; A new GSK?; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Endpoints News turned five years old last weekend! Longtime readers would see how far we’ve come, and it’s all thanks to you, our subscribers. If you enjoy our coverage, please read publisher Arsalan Arif’s note on how you can support us for the next phase of growth.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 113,500+ biopharma pros reading Endpoints daily — and it's free.